3rd Quarter - Report
SPLITOAK STRATEGIES LLC for ACCELERON PHARMA, INC
Client
Income
$30,000
Expenses
—
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
HR 3, Impact on rare disease research
| Lobbyist | Covered position, as disclosed |
|---|---|
| SARAH KUEHL EGGE New | 1998-2000, Legislative Assistant, Senator Bob Kerrey; 2001-2012 Senior Budget Analyst, Democratic Staff, Senate Budget Committee; Fall 2011, Deputy Staff Director, Joint Select Committee on Deficit Reduction |
| AMY JENSEN | Special Assistant to the President for Legislative Affairs (2003-2005); Assistant to the Speaker for Policy (1999-2001); Policy Analyst, Office of the Majority Whip (1995-1999) |
Health Issues HCR
HR 3, impact on rare disease research
| Lobbyist | Covered position, as disclosed |
|---|---|
| SARAH KUEHL EGGE New | Legislative Assistant, Sen. Bob Kerrey (1998-2000); Senior Budget Analyst, Senate Budget Committee (2001-2012); Deputy Staff Director, Joint Select Committee on Deficit Reduction (Fall 2011) |
| AMY JENSEN | Special Assistant to the President (2003-2005); Assistant to the Speaker for Policy (1999-2001); Policy Analyst, Office of the Majority Whip (1995-1999) |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.